newsfilter
← Latest News
GlobeNewswire·

Ziopharm Comments on Delay of WaterMill’s Stated Consent Deadline

Ziopharm Recommends Shareholders Return the GREEN Consent Revocation Card BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today...